Related Experiment Video
Updated: Sep 1, 2025

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
Published on: October 15, 2018
Thalassemia in Viet Nam
Khanh Q Bach1, Ha T T Nguyen1, Thanh H Nguyen1
1Thalassaemia Centre, National Institute of Hematology and Blood Transfusion, Hanoi, Viet Nam.
In Vietnam, 13.8% of the population carry thalassemia genes, with significant ethnic and regional variations. Prevention programs focus on prenatal diagnosis to reduce new thalassemia births.
Area of Science:
- Genetics
- Public Health
- Hematology
Background:
- Thalassemia is a significant public health concern in Vietnam, affecting 13.8% of the 96.2 million population.
- Carrier rates and specific globin gene mutations exhibit considerable ethnic and geographic diversity across the country's 54 ethnic groups.
Purpose of the Study:
- To analyze the prevalence and distribution of thalassemia/hemoglobinopathy gene carriers in Vietnam.
- To understand the ethnic and topographic variations in thalassemia gene carrier rates and mutations.
- To inform public health strategies for thalassemia prevention and control.
Main Methods:
- Population-based carrier screening for thalassemia genes.
- Analysis of gene carrier rates and globin gene mutation frequencies.
- Geographic and ethnic stratification of data.
Main Results:
- Overall carrier rate is 13.8% across all 54 ethnic groups.
- High prevalence of alpha(0)-thalassemia and beta(0)-thalassemia in Northern Highland ethnic groups.
- High prevalence of alpha(+)-thalassemia and Hb E (HBB: c.79G>A) in Southern Middle region ethnic groups.
- Carrier rates range from 0.23% in La Hu to 88.6% in Raglai ethnic groups.
Conclusions:
- Thalassemia prevention and control programs in Vietnam utilize prenatal and neonatal diagnosis to minimize new births of affected individuals.
- Current management for existing thalassemia patients relies on supportive care, including blood transfusions and iron chelation.
- Hematopoietic stem cell transplantation offers a curative option but is accessible to a limited patient subset.
More Related Videos
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Related Concept Videos
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Multiple Allele Traits
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Incomplete Dominance
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Cardiomyopathy III: Hypertrophic Cardiomyopathy